RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $496
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice TargetHot
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $435 to $496.
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $435 to $496.